Survivorship & Supportive Care - Cancer Currents Blog
News on research that affect cancer patients and survivors. Topics include managing treatment side effects, fertility preservation, and cancer’s long-term effects.
-
Black and Hispanic patients nearing the end of life are less likely than White patients to get opioids needed to control their cancer pain, a new study shows. Black patients were also more likely than White patients to undergo urine tests that screen for drugs.
-
Many young women who are diagnosed with early-stage breast cancer want to become pregnant in the future. New research suggests that these women may be able to pause their hormone therapy for up to 2 years as they try to get pregnant without raising the risk of a recurrence in the short term.
-
mRNA COVID-19 vaccines did not increase the type, frequency, or severity of immune-related side effects among people taking immune checkpoint inhibitors to treat cancer, a study at Memorial Sloan Kettering Cancer Center found. CDC and other medical groups generally recommend that people with cancer receive an mRNA COVID-19 vaccine.
-
Cisplatin raises levels of a fat molecule called S1P in areas of the brain responsible for memory and information processing, a new study shows. S1P locks onto a protein on the surface of brain cells called S1PR1. In mice given cisplatin, drugs that block S1PR1 prevented cognitive problems.
-
Results from a large NCI-funded clinical trial show that steroids were no more effective than a placebo for treating breathing problems in people with advanced cancer. And people treated with steroids were more likely to have serious side effects.
-
The chemotherapy cisplatin often causes permanent hearing loss. Sodium thiosulfate (Pedmark) is the first treatment approved by FDA that can reduce the risk of hearing loss and the severity of damage to the inner ear in children treated with cisplatin.
-
Regular visits and calls from community health workers showed many benefits for those with advanced cancers, from greater use of palliative care to improved quality of life, a new study has shown.
-
About 25% of cancer survivors have persistent anxiety, depression, or other psychological and social (psychosocial) distress. In this interview, Dr. Patricia Ganz discusses psychosocial distress and the challenges and opportunities in this area.
-
After surgery for early-stage, low-risk testicular cancer, it’s safe to monitor for a recurrence using MRI scans or fewer CT scans than are currently used, according to results from a large clinical trial.
-
Women are more likely than men to experience severe side effects from cancer treatments such as chemotherapy, targeted therapy, and immunotherapy, a new study finds. Researchers hope the findings will increase awareness of the problem and help guide patient care.